• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    New insider Nina Capital Holdings Inc. claimed ownership of 2,065,500 shares (SEC Form 3)

    10/18/24 8:17:54 PM ET
    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $PETS alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    NINA CAPITAL HOLDINGS INC.

    (Last) (First) (Middle)
    17301 BISCAYNE BLVD., APT 2205

    (Street)
    AVENTURA FL 33160

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    09/09/2024
    3. Issuer Name and Ticker or Trading Symbol
    PETMED EXPRESS INC [ PETS ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    X Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Common Stock 2,065,500(1) D
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    1. Name and Address of Reporting Person*
    NINA CAPITAL HOLDINGS INC.

    (Last) (First) (Middle)
    17301 BISCAYNE BLVD., APT 2205

    (Street)
    AVENTURA FL 33160

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    TACHE GALANTE MOISES

    (Last) (First) (Middle)
    17301 BISCAYNE BLVD., APT 2205

    (Street)
    AVENTURA FL 33160

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    MATZ ZYMAN STEPHANNIE

    (Last) (First) (Middle)
    17301 BISCAYNE BLVD., APT 2205

    (Street)
    AVENTURA FL 33160

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    Explanation of Responses:
    1. Includes (i) 1,537,500 shares of Common Stock held by Nina Capital Holdings, and (ii) 528,000 shares of Common Stock held jointly by Moises Tache Galante and his spouse, Stephannie Matz Zyman.
    Remarks:
    See Exhibit 99.1 to this Form 3 for the joint filing agreement by and among each Reporting Person, which joint filing agreement is incorporated herein by reference.
    /s/ Moises Tache Galante as director of Nina Capital Holdings Inc. 10/18/2024
    /s/ Moises Tache Galante 10/18/2024
    /s/ Stephannie Matz Zyman 10/18/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $PETS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PETS

    DatePrice TargetRatingAnalyst
    5/25/2023$20.00Buy
    Lake Street
    1/25/2022$25.00 → $21.00Underweight
    Morgan Stanley
    1/20/2022$32.00Neutral → Buy
    Sidoti
    11/18/2021$25.00Underweight
    Morgan Stanley
    10/1/2021$28.00Hold
    Jefferies
    8/5/2021$22.00Underperform
    Credit Suisse
    More analyst ratings

    $PETS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • PetMed Express, Inc. Announces Delay in Fourth Quarter and Fiscal Year End Earnings Release and Conference Call

      DELRAY BEACH, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced it is delaying the release of the Company's fourth quarter and fiscal year 2025 earnings release and subsequent conference call, which had been scheduled for June 10, 2025, because the Company requires additional time to complete the year-end audit process. The Company anticipates that it will issue the earnings release, hold the related conference call, and file its Annual Report on Form 10-K as soon as possible, but no later than June 16, 2025. About PetMed Express, Inc. Founded in 1996, PetMeds is a leader in pioneering the digital pet p

      6/10/25 4:05:00 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2025 Earnings Call

      DELRAY BEACH, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Tuesday, June 10, 2025 at 4:30pm Eastern Time to discuss its financial results for the fourth quarter and full fiscal year ended March 31, 2025. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Tuesday, June 10, 2025Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8562We

      5/27/25 4:05:00 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express, Inc. and Dutch Announce Partnership to Provide Accessible Telehealth Services for Pets

      DELRAY BEACH, Fla. and OAKLAND, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., parent company of PetMeds and PetCareRx (NASDAQ:PETS), today announced a new strategic partnership with virtual veterinary care provider Dutch. The collaboration marks PetMeds' latest move to expand its provider ecosystem with affordable, accessible pet healthcare options. The new partnership will enable pet parents to leverage Dutch's convenient technology and veterinary team to secure prescriptions for PetMeds' broad selection of medications in a timely manner. "This partnership expands the accessibility of pet telemedicine, which can help fill gaps in care, as the nationwide vet shortage has

      5/7/25 9:08:06 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $PETS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Nina Capital Holdings Inc. bought $98,375 worth of shares (25,000 units at $3.94), increasing direct ownership by 0.99% to 2,550,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      6/4/25 4:15:58 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Large owner Nina Capital Holdings Inc. bought $96,500 worth of shares (25,000 units at $3.86), increasing direct ownership by 1% to 2,525,000 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      5/23/25 4:15:13 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Large owner Silvercape Investments Ltd bought $29,234 worth of shares (7,401 units at $3.95), increasing direct ownership by 0.32% to 2,307,719 units (SEC Form 4)

      4 - PETMED EXPRESS INC (0001040130) (Issuer)

      5/22/25 10:55:21 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $PETS
    SEC Filings

    See more
    • PetMed Express Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - PETMED EXPRESS INC (0001040130) (Filer)

      4/9/25 9:24:45 AM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form 10-Q filed by PetMed Express Inc.

      10-Q - PETMED EXPRESS INC (0001040130) (Filer)

      2/10/25 5:14:56 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • PetMed Express Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - PETMED EXPRESS INC (0001040130) (Filer)

      2/10/25 5:12:32 PM ET
      $PETS
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples